Kantar Health, a healthcare consultancy and marketing insights company, is pleased to announce that Hettie Han has re-joined Kantar Health China as its director.

Based in Beijing, Han will work on further strengthening the company’s local marketing insights practice. She will also work with the global team to grow China’s multi-client and consultancy business.

Han re-joins Kantar Health from TBL Consulting. With more than 14 years of healthcare research experience, she also has held analyst roles at several US and China-based pharma companies, including Bristol-Myers Squibb, Penwest, Purdue and Kunming Pharmaceuticals.

“We’re very excited that Hettie has decided to re-join us at Kantar Health China,” said Simon Li, general manager of Kantar Health China. “During her previous tenure with us, Hettie was instrumental in building our business in this key market for the healthcare industry. She has deep experience across a variety of therapeutic areas and has proven herself to be a trusted adviser to her pharma-industry clients, from recognising their business issues to collaborating with them to provide the right solutions.”